London law firm Kaye Scholer is urging European managers to seize the opportunities available to them under the Term Asset-Backed Securities Loan Facility ("TALF") by launching new funds as soon as possible.

Healthcore Management, King Street Capital Management and Paulson & Co. are the nominees for AIN sister publication Foundation & Endowment Money Management’s Hedge Fund Manager of the Year award—one of three alternatives categories.

Simon Mullaly, an ex-head of distressed trading at Deutsche Bank in London, is working on launching a credit investment boutique along with Lars Lemonius, an ex-Morgan Stanley portfolio manager in London.

Aramid Capital Partners is hosting a charity cricket match on Monday, at the Honourable Artillery Company in London.

Alessandro Dal Cin, formerly a director in equity derivative sales to hedge funds in London for Citigroup, has joined Newedge’s equity derivatives broking team.

London law firm Kaye Scholer is urging European managers to seize the opportunities available to them under the Term Asset-Backed Securities Loan Facility ("TALF") by launching new funds as soon as possible.

Headline Capital Management, a Charlotte, N.C., quantitative hedge fund firm, has today rolled out its third fund, the Headline Mercury Fund.

GLG Partners has made its first move to offer hedge fund strategies via the Ucits structure by launching the GLG Pure Alpha (Ucits III) Fund.

Security Global Investors has launched a new long/short commodities fund and is considering future funds in distressed debt, long/short real estate, private equity and clean technologies.

RD Legal Capital, which manages a hedge fund focused on litigation financing, is seeking money from foundations, endowments and pensions as it hopes to raise assets to $200-400 million.

Long/short equity technology-focused hedge fund ChipInvestor Group is in buying-mode, staying 80-90% long with its only shorts being hedges.

For its long book global healthcare firm Arcoda Capital Management is sticking to companies it believes will not be affected no matter what healthcare reform the U.S. Congress decides upon later this year—those which produce “orphan” drugs, or drugs developed specifically to treat a rare medical condition.

T.I.P. Wealth Manager, a C$60 million Toronto firm focused on North American equities, has adopted a ‘barbell’ approach by emphasizing cyclical stocks in the energy, materials and technology sectors while keeping a large proportion of its remaining assets in cash.

Meadowbrook Capital Management is changing tack in marketing its Meadowbrook Beta Neutral Fund.

Altis Partners, the $1.3 billion Jersey CTA firm, is planning to open an office in either Hong Kong or, more likely, Singapore by the end of the year.

Newly-formed OPVS Group in Singapore is zeroing in on a private debt fund and a long/short public credit strategy.

Griffin Capital Management, the London and Gibraltar firm focused on European long-only and long/short equity strategies, is registering its funds in Switzerland in an attempt to boost its prominence with investors there.

Tokyo-based Myojo Asset Management is looking for a seeding firm to invest $50 million in its recently launched Myojo Super Cycle Long/Short Fund.

"For funds of funds to succeed they are going to have to change the way they do business," particularly if they are to attract money from larger investors, believes Brian Altenburg, a managing director in alternative investment asset management at Bank of America.

Hedge funds, pension funds and asset managers have been increasingly turning back to using property derivatives in Europe over the past few weeks as they develop a more positive outlook on the real estate market, identifying areas of dislocation for trading.

Despite increased hedge fund regulation, other parts of the reform package may not be entirely negative for the industry, according to Jill Whitelaw of law firm Montgomery McCracken.